Eurostars 2023

• Eurostars funds the αTREAT project and has also agreed to partially fund a First-in-Human diagnostic study to accelerate the development of a novel PSMA-targeted therapy for metastatic prostate cancer. This collaboration brings together TetraKit, Elysia-Raytest, and Rigshospitalet’s expertise in radiopharmaceutical technology and astatine-211 production.

Eurostars 2024

• €1 million awarded for the PRE-CISE project (2025–2027), in collaboration with Akiram Therapeutics and PreTT, to develop targeted alpha therapies using an innovative pretargeting system. Read more about the collaboration here: https://shorturl.at/liJ1q